Skip to main content

$6.600 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
20 June 2025 at 7:23pm
Register to track MDC and receive email alerts.
Subject
MDC Ann: Addendum to Appendix 4C

MDC Ann: Jefferies Healthcare Conference Presentation

MDC Ann: Jefferies Healthcare Conference Webcast Link

MDC Ann: Synthetic formulation in pending global PIII Trial

MDC Ann: Medlab Presenting at Jefferies Global Healthcare Conference

MDC Ann: Appointment of CFO & Company Secretary

MDC Ann: Notice under Section 708A(5)(e) of the Corporations Act

MDC Ann: Notice under Section 708A(5)(e) of the Corporations Act

MDC Ann: Appendix 2A

MDC Ann: Appendix 2A

MDC Ann: Appendix 2A

MDC Ann: Results of Meeting

MDC Ann: Chairman's Address to Shareholders

MDC Ann: Reminder of Investor Webinar - NanaBis Phase III Trial

MDC Ann: Appendix 4C - monthly

MDC Ann: Appendix 4C - quarterly

MDC Ann: NanaBis Observational Study progress update

MDC Ann: Notification of Investor Webinar - NanaBis Phase III Trial

MDC Ann: Intention to Grant EU Notice NanoCelle

MDC Ann: Executive and Management changes

MDC Ann: Ceasing to be a substantial holder x 2

MDC Ann: Change in substantial holding

MDC Ann: Notice under Section 708A(5)(e) of the Corporations Act

MDC Ann: Notice of Extraordinary General Meeting/Proxy Form

MDC Ann: Appendix 2A

MDC Ann: Leading Pharmaceutical Executive joins Medlab Board

MDC Ann: Proposed issue of Securities - MDC

MDC Ann: Proposed issue of Securities - MDC

MDC Ann: Successful Completion of $15 million Placement

MDC Ann: Trading Halt

MDC Ann: Pause in Trading

MDC Ann: Half Yearly Report and Accounts

MDC Ann: Appendix 4D

MDC Ann: HOA with Arrotex to accelerate NanoCB access for Pharmacy

MDC Ann: Medlab Receives Positive Depression Trial Prelim Results

MDC Ann: Appendix 4C - quarterly

MDC Ann: Corporate Update

MDC Ann: NanaBis IND Presentation - Webinar

MDC Ann: FDA Grants an IND for NanaBis and Investor Webcast

MDC Ann: Change of Director's Interest Notice

MDC Ann: 2020 Research Program Update

MDC Ann: NanaBis Observational Study Progression Report

MDC Ann: Appendix 3Y x 4

MDC Ann: Appendix 3G

MDC Ann: Proposed issue of Securities - MDC

MDC Ann: Proposed issue of Securities - MDC

MDC Ann: NanaBis P3 Trial Launching in the UK with support from NIHR

MDC Ann: Appendix 4C - quarterly

MDC Ann: Results of Meeting

MDC Ann: AGM Presentation

Register to track MDC and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX